Literature DB >> 18407797

Hepatitis C infection with normal liver chemistry tests.

Michael W Fried1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18407797      PMCID： PMC3095433          DOI： 10.1016/j.cgh.2008.02.040

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  11 in total

Review 1.  National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C 2002 (June 10-12, 2002).

Authors: 
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

2.  Chronic hepatitis C in patients with persistently normal alanine transaminase levels.

Authors:  Mitchell L Shiffman; Moisés Diago; Albert Tran; Paul Pockros; Robert Reindollar; Daniele Prati; Maribel Rodríguez-Torres; Pilar Lardelli; Steven Blotner; Stefan Zeuzem
Journal:  Clin Gastroenterol Hepatol       Date:  2006-05       Impact factor: 11.382

3.  Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years.

Authors:  M Persico; S Perrotta; E Persico; L Terracciano; A Folgori; L Ruggeri; A Nicosia; R Vecchione; V L Mura; M Masarone; R Torella
Journal:  J Viral Hepat       Date:  2006-05       Impact factor: 3.728

4.  Diagnosis, management, and treatment of hepatitis C.

Authors:  Doris B Strader; Teresa Wright; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2004-04       Impact factor: 17.425

5.  American Gastroenterological Association medical position statement on the management of hepatitis C.

Authors:  Jules L Dienstag; J G McHutchison
Journal:  Gastroenterology       Date:  2006-01       Impact factor: 22.682

6.  Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.

Authors:  Hari S Conjeevaram; Michael W Fried; Lennox J Jeffers; Norah A Terrault; Thelma E Wiley-Lucas; Nezam Afdhal; Robert S Brown; Steven H Belle; Jay H Hoofnagle; David E Kleiner; Charles D Howell
Journal:  Gastroenterology       Date:  2006-08       Impact factor: 22.682

Review 7.  Review article: management of patients with chronic hepatitis C virus infection and "normal" alanine aminotransferase activity.

Authors:  S Zeuzem; A Alberti; W Rosenberg; P Marcellin; M Diago; F Negro; D Prati; C Puoti; S K Roberts; M L Shiffman
Journal:  Aliment Pharmacol Ther       Date:  2006-10-15       Impact factor: 8.171

8.  Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels.

Authors:  Stefan Zeuzem; Moisés Diago; Edward Gane; K Rajender Reddy; Paul Pockros; Daniele Prati; Mitchell Shiffman; Patrizia Farci; Norman Gitlin; Christopher B O'Brien; François Lamour; Pilar Lardelli
Journal:  Gastroenterology       Date:  2004-12       Impact factor: 22.682

9.  Updated definitions of healthy ranges for serum alanine aminotransferase levels.

Authors:  Daniele Prati; Emanuela Taioli; Alberto Zanella; Emanuela Della Torre; Sonia Butelli; Emanuela Del Vecchio; Luciana Vianello; Francesco Zanuso; Fulvio Mozzi; Silvano Milani; Dario Conte; Massimo Colombo; Girolamo Sirchia
Journal:  Ann Intern Med       Date:  2002-07-02       Impact factor: 25.391

Review 10.  Performance of serum marker panels for liver fibrosis in chronic hepatitis C.

Authors:  Julie Parkes; Indra Neil Guha; Paul Roderick; William Rosenberg
Journal:  J Hepatol       Date:  2005-11-21       Impact factor: 25.083
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.